Buviren Tablet

About Buviren 400 mg Tablet

Buviren 400 mg Tablet is an antiviral medicine used as part of combination treatment for chronic hepatitis C. It works by blocking the virus from copying itself inside the body.

There are 2 brands of Sofosbuvir listed in Bangladesh. By unit price, Buviren is among the cheapest of them.

What is Buviren 400 mg Tablet?

Buviren 400 mg Tablet is an antiviral medicine containing the active ingredient Sofosbuvir. It belongs to a group of medicines used to treat hepatitis C, a viral infection that affects the liver. This medicine works by interfering with the process the hepatitis C virus uses to reproduce itself, which helps reduce the amount of virus in the body. It is always taken together with other antiviral medicines as part of a treatment plan chosen by a doctor. Buviren comes as a tablet in a pack of 1 x 6. Treatment is supervised by a qualified physician.

Uses of Buviren

Buviren 400 mg Tablet is used to treat chronic hepatitis C infection in adults, as one part of a combination antiviral treatment plan. It is not used on its own; doctors combine it with other antiviral medicines depending on the type of hepatitis C virus involved. The doctor will decide the right combination and course for each patient after appropriate testing. Ask your doctor if you have questions about why this medicine has been prescribed for you.

How to use Buviren

Buviren 400 mg Tablet is taken by mouth as directed by your doctor. The doctor decides the dose and how long you take it, and it is usually taken together with other antiviral medicines. Follow your doctor's instructions carefully and do not change the schedule on your own. If you miss a dose, ask your doctor or pharmacist what to do. Do not stop the medicine early without medical advice, even if you feel well.

Side effects of Buviren

When used in combination with other antiviral medicines, common side effects can include tiredness and headache. Other effects reported with combination therapy include nausea, trouble sleeping, low red blood cell counts, itching, rash, reduced appetite, chills, fever, diarrhoea, muscle pain and irritability. Tell your doctor or pharmacist if you notice any side effects or if they bother you. Do not treat side effects yourself without asking a healthcare professional.

Safety and precautions

Before taking Buviren 400 mg Tablet, tell your doctor about all your health conditions and all medicines you take. Serious slow heartbeat has been reported when amiodarone is used with this type of medicine together with another direct-acting antiviral, so your doctor needs to know if you take amiodarone or heart medicines. Combination treatment that includes ribavirin or peginterferon is not suitable in pregnancy because of risks to the baby, and pregnancy should be discussed with the doctor first. It is not known whether Sofosbuvir passes into breast milk. Ask your doctor before use if you are pregnant, planning pregnancy or breastfeeding.

Frequently asked questions

What is the price of Buviren 400 mg Tablet?

The listed price is ৳ 600.00.

How should I store Buviren 400 mg Tablet?

Keep it in a cool and dry place, away from light, and out of the reach of children. Ask your pharmacist if you need more advice on storage.

What is Buviren 400 mg Tablet used for and what kind of medicine is it?

It is an antiviral medicine containing Sofosbuvir, used as part of combination treatment for chronic hepatitis C infection. Your doctor decides the treatment plan and the other medicines used with it.

Which medicines may interact with Buviren 400 mg Tablet?

It can interact with drugs such as rifampicin, St. John's wort, carbamazepine, phenytoin, modafinil, phenobarbital, oxcarbazepine, rifabutin and rifapentine. Serious slow heartbeat may occur with amiodarone and another direct-acting antiviral. Tell your doctor and pharmacist about all medicines you take.

Tablet
Generic name
Sofosbuvir
Strength
400 mg
Dosage form
Tablet
Manufactured by
Renata PLC.
Price in Bangladesh

৳ 588 ৳ 600.00 2% off unit price

Price updated: 18 Nov 2026

Indications

Sofosbuvir is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.

Sofosbuvir efficacy has been established in subjects with HCV genotype 1, 2, ... Read moreSofosbuvir is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.

Sofosbuvir efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infection, including those with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and those with HCV/HIV-1 co-infection.

The following points should be considered when initiating treatment with Sofosbuvir:
  • Monotherapy of Sofosbuvir is not recommended for treatment of CHC.
  • Treatment regimen and duration are dependent on both viral genotype and patient population.
  • Treatment response varies based on baseline host and viral factor.

Pharmacology

Sofosbuvir is nucleotide analog inhibitor, which specifically inhibits HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Following intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), sofosbuvir incorporates into HCV RNA by the NS5B polymerase and acts as a chain terminator. More specifically, Sofosbuvir prevents HCV viral replication by binding to the two Mg2+ ions present in HCV NS5B polymerase's GDD active site motif and preventing further replication of HCV genetic material

Dosage & Administration

One 400 mg tablet taken once daily with or without food. Should be used in combination with Ribavirin or in combination with Pegylated Interferon and Ribavirin for the treatment of CHC.

Recommended combination therapy: (HCV Mono-infected and HCV/HIV-1 Co-infected)-
  • Genotype 1 or 4: Sofosbuvir + Peginterferon alfa + Ribavirin for 12 weeks
  • Genotype 2: Sofosbuvir + Ribavirin for 12 weeks
  • Genotype 3: Sofosbuvir + Ribavirin for 24 weeks
Sofosbuvir in combination with Ribavirin for 24 weeks can be considered for CHC patients with genotype 1 infection who are Interferon ineligible

Should be used in combination with Ribavirin for treatment of CHC in patients with hepatocellular carcinoma awaiting liver transplantation for up to 48 weeks or until liver transplantation whichever occurs first

A dose recommendation cannot be made for patients with severe renal impairment or end stage renal disease

Interaction

Reduced therapeutic effect with drugs that are potent P-gp inducers in the intestine (eg rifampicin, St. John's wort, carbamazepine & phenytoin), modafinil, phenobarb/ oxcarbazepine, rifabutin/ rifapentine. P-gp &/or BCRP inhibitors. May result in serious symptomatic bradycardia when co-administered with amiodarone in combination with another direct acting antiviral.

Contraindications

When Sofosbivur is used in combination with Ribavirin or Peginterferon alfa/ Ribavirin, the contraindications applicable to those agents are applicable to combination therapies. Sofosbuvir combination treatment with Ribavirin or Peginterferon alfa/Ribavirin is contraindicated in women who are pregnant or may become pregnant and men whose female partners are pregnant, because of the risks for birth defects and fetal death associated with Ribavirin.

Side Effects

The most common adverse events (incidence greater than or equal to 20%, all grades) observed with Sofosbuvir in combination with Ribavirin were fatigue and headache. The most common adverse events observed with Sofosbuvir in combination with Peginterferon alfa and Ribavirin were fatigue, headache, nausea, insomnia, anemia, pruritus, asthenia, rash, decreased appetite, chills, influenza like illness, pyrexia, diarrhea, neutropenia, myalgia, irritability.

Pregnancy & Lactation

Pregnancy Category B: Sofosbuvir There are no adequate and well-controlled studies with Sofosbuvir in pregnant women.

Nursing Mothers: It is not known whether Sofosbuvir and its metabolites are present in human breast milk.

Precautions & Warnings

Bradycardia with amiodarone co-administration: Serious symptomatic bradycardia may occur in patients taking amiodarone and Sofosbuvir in combination with another direct acting antiviral (DAA), particularly in patients also receiving beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease. Co-administration of amiodarone with Sofosbuvir in combination with another DAA is not recommended. In patients without alternative, viable treatment options, cardiac monitoring is recommended.

Overdose Effects

The highest dose of Sofosbuvir is a single dose of Sofosbuvir 1200 mg. No specific antidote is available for overdose treatment. Treatment of overdose with Sofosbuvir consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient.

Storage Conditions

Keep out of the reach of children. Keep in a cool & dry place. Protect from light.

Alternative brands of Sofosbuvir

Other brands with the same generic name, cheapest first.

Sofomax Tablet

400 mg

Sofosbuvir

Advanced Chemical Industries PLC

৳ 686 ৳ 700 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.